Novo Nordisk A/S (NYSE:NVO) Q4 2023 Earnings Call Transcript

Novo Nordisk A/S beats earnings expectations. Reported EPS is $4.91, expectations were $0.66.

Related Keywords

United States ,Japan ,France ,Kalundborg ,Sjæand ,Denmark ,China ,Danish ,America ,Pete Verdult ,Lars Fruergaard ,Doug Langa ,Novo Nordisk ,Daniel Bohsen ,Inversago Pharma ,Peter Verdult ,Mike Nedelcovych ,Lilly Zepbound ,Louise Chen ,Lars Fruergaard Jorgensen ,Camilla Sylvest ,Martin Holst Lange ,Daniel Muusmann Bohsen ,Karsten Munk Knudsen ,Michael Nedelcovych ,Corporate Affairs ,International Operations ,Citigroup ,Head Of Development ,Call Transcript January ,Nordisk Earnings Conference ,Novo Nordisk Earnings Call ,Investor Relations ,Executive Vice President ,Commercial Strategy ,North America Operations ,Chief Financial Officer ,Karsten Munk ,Fruergaard Jorgensen ,North America ,Diabetes Care ,Holst Lange ,Western Ontario ,Mcmaster Universities Osteoarthritis Index ,Kansas City Cardiomyopathy ,Munk Knudsen ,Forma Therapeutics ,Annual General Meeting ,Acne Treatment Products For Teens ,Selling Cancer ,